IBDIQ

LIVE

Serial Number

98584115

Owner

Takeda Pharmaceuticals U.S.A., Inc.

Attorney

Karl M. Zielaznicki, Esq.

Filing Date

Jun 4, 2024

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

IBDIQ Trademark

Serial Number: 98584115 • Registration: 8306168

IBDIQ is a trademark filed by Takeda Pharmaceuticals U.S.A., Inc. on June 4, 2024. The trademark is classified under Class 44 (Medical Services). The application is currently registered and active.

Trademark Classes

Class 44 - Medical Services

Medical services; veterinary services; hygienic and beauty care for human beings or animals

Owner Contact Info

Takeda Pharmaceuticals U.S.A., Inc.

500 Kendall Street
Cambridge, MA 02142

Entity Type: 03

Legal Representation

Attorney of Record

Karl M. Zielaznicki, Esq.

907 trademarks filed View all →

Correspondence Address

Karl M. Zielaznicki, Esq. Troutman Pepper Locke LLP

875 Third Avenue

c/o IP Services NYC

New York, NY 10022

United States

Trademark Details

Filing Date

June 4, 2024

Registration Date

June 16, 2026

Published for Opposition

April 15, 2025

Goods & Services

Healthcare provider and medical professional support program providing disease awareness and disease management information and materials in the nature of providing a website featuring medical information to improve the understanding of healthcare providers and medical professionals about inflammatory bowel disease (IBD) and pharmaceutical treatment thereof

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Jun 16, 2026 NRCC

REGISTERED-PRINCIPAL REGISTER

Jun 16, 2026 R.PR

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

May 27, 2026 SUNA

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

May 27, 2026 CNPR

STATEMENT OF USE PROCESSING COMPLETE

Apr 18, 2026 SUPC

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Apr 18, 2026 AITU

USE AMENDMENT FILED

Nov 17, 2025 IUAF

TEAS STATEMENT OF USE RECEIVED

Nov 17, 2025 EISU

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Nov 11, 2025 TCCA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Nov 11, 2025 ARAA

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Nov 11, 2025 REAP

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Jun 10, 2025 NOAM

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Apr 15, 2025 NPUB

PUBLISHED FOR OPPOSITION

Apr 15, 2025 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Apr 9, 2025 NONP

APPROVED FOR PUB - PRINCIPAL REGISTER

Mar 21, 2025 CNSA

TEAS/EMAIL CORRESPONDENCE ENTERED

Feb 17, 2025 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Feb 17, 2025 CRFA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Feb 17, 2025 TROA

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Dec 20, 2024 GNRN

NON-FINAL ACTION E-MAILED

Dec 20, 2024 GNRT

NON-FINAL ACTION WRITTEN

Dec 20, 2024 CNRT

ASSIGNED TO EXAMINER

Dec 16, 2024 DOCK

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Aug 3, 2024 NWOS

NEW APPLICATION ENTERED

Jun 4, 2024 NWAP

Related Trademarks

More from this Owner

Serial #99516292

MIMRYLO

MIMRAYO

More in Same Class

MERCY BIOANALYTICS CANCER SCREENING FOREVERYONE

PERFORMANCE THERAPEUTICS PHYSICAL THERAPY & SPORTS MEDICINE

LIFE AS YOU WANT IT. CARE AS YOU NEED IT.

MERCY BIOANALYTICS

CREDO MEMORY CARE

MULTICULTURAL CLINICAL SERVICES, LLC